Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
Clinical trial NCT07469306 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07469306
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2027-08-10
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.